Trial intelligence / Profile preview

Ketamine and Mindfulness-Based Relapse Prevention for Cocaine Dependence

NCT01535937Phase 2Terminated

Sponsor
New York State Psychiatric Institute
Start
Feb 2012
Primary completion
Jan 2017
Countries
1
01

Overview

A Phase 2 trial of ketamine in cocaine dependence, sponsored by New York State Psychiatric Institute. Started Feb 2012; status: terminated.

02

Drugs

ketamine
03

Conditions

cocaine dependence

Beyond the preview

Go deeper on NCT01535937.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01535937.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call